{
    "nct_id": "NCT04660929",
    "official_title": "A Phase 1, First in Human Study of Adenovirally Transduced Autologous Macrophages Engineered to Contain an Anti-HER2 Chimeric Antigen Receptor in Subjects With HER2 Overexpressing Solid Tumors",
    "inclusion_criteria": "* HER2-positive recurrent or metastatic solid tumors for which there are no available curative treatment options.\n\n  * Breast cancer and gastric/gastroesophageal junction cancers must have failed approved HER2-targeted agents.\n  * Other HER2-positive tumor types must have failed standard of care therapies, while prior therapy with anti-HER2 drugs is not required.\n* Subject must be willing and able to undergo tumor tissue biopsy procedures\n* Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1\n* Subject has adequate bone marrow and organ function\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* HIV, active hepatitis B or hepatitis C infection.\n* Diagnosis of immunodeficiency or chronic exposure to systemic corticosteroid therapy or any other form of immunosuppressive therapy\n* Untreated or symptomatic central nervous system (CNS) metastases or cytology proven carcinomatous meningitis.\n\n  o Subjects with small, asymptomatic CNS metastases that do not require treatment are permitted to enroll.\n* Left ventricular ejection fraction (LVEF) <50% as determined by ECHO or multiple gated acquisition scan (MUGA)\n\nOther protocol-defined Inclusion/Exclusion may apply.\n\nCT-0508 in Combination with Pembrolizumab Substudy Only:\n\nExclusion Criteria:\n\n* Subjects with severe hypersensitivity (â‰¥Grade 3) to pembrolizumab and/or any of its excipients\n* Subjects with an active autoimmune disease that has required systemic treatment in past 2 years (i.e., with use of disease modifying agents, corticosteroids or immunosuppressive drugs).\n* Subjects who have a history of (non-infectious) pneumonitis/interstitial lung disease that required steroids or has current pneumonitis/interstitial lung disease\n* Subjects who have had an allogeneic tissue/solid organ transplant",
    "miscellaneous_criteria": ""
}